Dr. Jeffrey L. Jorgensen, MD, PhD

Dr. Jorgensen practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Jorgensen's NPI, 1255420923, was assigned on October 12, 2006. Dr. Jorgensen graduated from Stanford University School Of Medicine in 1994. Dr. Jorgensen holds Texas license K6029.

Dr. Jorgensen's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Jorgensen's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jorgensen practices. Vendor and product names are available with a free account.

Hematology is Dr. Jorgensen's primary specialty in the NPI Registry, under taxonomy code 207ZH0000X. Dr. Jorgensen is board certified in anatomic pathology by the American Board of Pathology. Dmand AI has Dr. Jorgensen's licenses on file in 2 states: Texas and Massachusetts.

CMS data shows 1,537 Medicare services from Dr. Jorgensen across 11 procedure codes in 2024, for 531 Medicare patients. Medicare paid $49,573 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 531 Medicare patients who saw Dr. Jorgensen in 2024. The largest group is 65 to 74, with 280 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 5% are also on Medicaid. Their average risk score is 3.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jorgensen's median patient age at 67, with 45% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Jorgensen for performance year 2024, reported as part of a group.

Dmand AI links 134 papers to Dr. Jorgensen, published from 2005 to 2025. 2018 was the busiest year, with 13. The most frequent topics are Flow Cytometry, Antineoplastic Combined Chemotherapy Protocols and Immunophenotyping. Dr. Jorgensen has published most often in Blood. Dr. Jorgensen's most frequent co-authors are Hagop M. Kantarjian, MD, Sa A. Wang, MD and Leonard Jeffrey Medeiros, MD.

CMS Open Payments shows 4 general payments to Dr. Jorgensen from 1 drug or device company from 2016 to 2020. Travel and lodging make up the largest share, 88% of the total. Becton, Dickinson and Company paid the most, $695.

Dr. Jorgensen graduated from Stanford University School Of Medicine in 1994.

Dr. Jorgensen is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.